OBJECTIVES: The severity of the effect in reducing the risk of sudden cardiac death has a significant positive impact on the forecast as a whole and significantly reduces overall mortality rate among different categories of cardiology patients. Meanwhile, it imposes a significant burden on the healthcare budget of the Republic of Kazakhstan. Due to the fact that the CD’s implantation is an expensive method of treatment, the authors conducted a review of existing studies on the cost-effectiveness of the CD in the application of additional functions - MRI-compatible and home monitoring function. METHODS: The literature review of the efficacy and safety «MRI-compatible CD with home monitoring» were conducted on the database of the Cochrane Library, a database of bibliographic review on the effectiveness of medical intervention (DARE), database reviews of health technology assessment (HTA), PubMED, CADTH, NICE, Clinical Trials and TripDatabase. RESULTS: Search results revealed 522 publications, and from this number 3 studies were selected for the final analysis. The remaining works were excluded due to non-compliance to the PICOS' criteria. According to the data from representatives Biotronik and Medtronic in Kazakhstan the CD’s cost without MRI-compatible, completed with electrodes in Kazakhstan ranges $18.000-19.000. CONCLUSIONS: Application in clinical practice, MRI-compatible CD with home monitoring has significant advantages - the almost complete absence of the risk of adverse events, the possibility of more frequent MRI as one of the main methods of diagnosis and early detection of various pathological conditions, the avoidance of unnecessary visits to patients without necessary evidence, revealing significant changes in the health status of patients in the constant monitoring; has a relatively small increase in the cost of a complete set of MRI-compatible CD with home monitoring in comparing with the cost of a set of CD without this function, an average of 33%.